These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2480302)

  • 21. Bone marrow transplantation in man. Analysis of T and B cell functions in PWM driven Ig production.
    Rümke HC; Terpstra FG; Roos MT; Vossen JM; Dooren LJ; Schellekens PT; Zeijlemaker WP
    Clin Exp Immunol; 1984 Aug; 57(2):467-78. PubMed ID: 6235992
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reconstitution of in vitro humoral immune function in bone marrow transplant recipients.
    Pollack S; O'Reilly RJ; Koziner B; Good RA; Hoffmann MK
    Immunobiology; 1986 Mar; 171(1-2):93-111. PubMed ID: 2940168
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abnormal T lymphocyte subpopulations in patients with B cell chronic lymphocytic leukemia: an analysis by monoclonal antibodies.
    Platsoucas CD; Galinski M; Kempin S; Reich L; Clarkson B; Good RA
    J Immunol; 1982 Nov; 129(5):2305-12. PubMed ID: 6214590
    [No Abstract]   [Full Text] [Related]  

  • 24. Fibronectin restores defective in vitro proliferation of lymphocytes from patients after marrow grafting.
    Klingemann HG; Tsoi MS; Storb R
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2646-7. PubMed ID: 3274574
    [No Abstract]   [Full Text] [Related]  

  • 25. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
    Russell CA
    Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distinct types of donor and recipient T cell clones functionally related to host-v-graft reactivity and autologous remission after bone marrow transplantation for severe aplastic anemia.
    Schneider EM; Pawelec G; Haen M; Ehninger G; Ostendorf P; Kömpf J; Schöllhorn V; Wernet P
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2620-5. PubMed ID: 2950637
    [No Abstract]   [Full Text] [Related]  

  • 27. [Characterization of GvH-related skin lesions using monoclonal antibodies on frozen sections].
    Müller C
    Verh Dtsch Ges Pathol; 1983; 67():362-6. PubMed ID: 6364603
    [No Abstract]   [Full Text] [Related]  

  • 28. Incomplete chimerism in erythroid, myeloid and B lymphocyte lineage after T cell-depleted allogeneic bone marrow transplantation.
    Schouten HC; Sizoo W; van 't Veer MB; Hagenbeek A; Löwenberg B
    Bone Marrow Transplant; 1988 Sep; 3(5):407-12. PubMed ID: 3056549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Transplantation of allogeneic bone marrow treated in vitro with Campath-1 monoclonal antibody].
    Chapuis B; Helg C; Maurice P; Wyss M; Pipard G; Irlé C; Jeannet M
    Schweiz Med Wochenschr; 1985 Oct; 115(43):1521-2. PubMed ID: 3909387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical correlations with cyclosporine blood levels after allogeneic bone marrow transplantation: an analysis of four different assays.
    Atkinson K; Downs K; Ashby M; Biggs J
    Transplant Proc; 1990 Jun; 22(3):1331-4. PubMed ID: 2190395
    [No Abstract]   [Full Text] [Related]  

  • 31. Role of immunoregulatory donor T cells in suppression of graft-versus-host disease following donor leukocyte infusion therapy.
    Johnson BD; Becker EE; LaBelle JL; Truitt RL
    J Immunol; 1999 Dec; 163(12):6479-87. PubMed ID: 10586039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone marrow transplantation in Basel: single center experience from 1973 to 1989.
    Speck B; Nissen C; Tichelli A; Roth J; Dazzi H; Stebler CH; Wernli M; Signer E; Gratwohl A
    Clin Transpl; 1989; ():115-22. PubMed ID: 2487556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lymphocyte subpopulations in acute experimental allergic encephalomyelitis in rhesus monkeys.
    van Lambalgen R; Meyran C; Zurcher C; Jonker M
    Prog Clin Biol Res; 1984; 146():99-104. PubMed ID: 6232624
    [No Abstract]   [Full Text] [Related]  

  • 34. Bone marrow transplantation: past experiences and future prospects.
    Thomas ED
    Semin Oncol; 1992 Jun; 19(3 Suppl 7):3-6. PubMed ID: 1615331
    [No Abstract]   [Full Text] [Related]  

  • 35. Primary human keratinocytes as targets in predicting acute graft-versus-host disease following HLA-identical bone marrow transplantation.
    van Dijk AM; Kessler FL; Verdonck LF; Stadhouders-Keet SA; van Lier RA; de Gast GC; Otten HG
    Br J Haematol; 2000 Dec; 111(3):791-6. PubMed ID: 11122139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibiton of IL 2 production after human allogeneic bone marrow transplantation.
    Azogui O; Gluckman E; Fradelizi D
    J Immunol; 1983 Sep; 131(3):1205-8. PubMed ID: 6224851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation.
    Keever-Taylor CA; Passweg J; Kawanishi Y; Casper J; Flomenberg N; Baxter-Lowe LA
    Bone Marrow Transplant; 1997 May; 19(10):1001-9. PubMed ID: 9169644
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human regulatory T-cell subsets.
    Young M; Geha RS
    Annu Rev Med; 1986; 37():165-72. PubMed ID: 2939789
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Lymphocyte subpopulations in multiple myeloma. Shift in the helper/suppressor cell relation].
    Ludwig H; Fritz E
    Acta Med Austriaca; 1982; 9(5-6):215-20. PubMed ID: 6219532
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Lymphocyte subpopulations in gestosis].
    Lellé RJ; Toboll G; Kaulhausen H; Heidenreich W
    Zentralbl Gynakol; 1986; 108(15):919-24. PubMed ID: 2945344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.